Carson Wealth (CWM LLC)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$279K Sell
3,717
-1,332
-26% -$105K ﹤0.01% 2436
2025
Q4
$399K Buy
5,049
+2,561
+103% +$193K ﹤0.01% 2062
2025
Q3
$163K Buy
2,488
+170
+7% +$8.3K ﹤0.01% 2603
2025
Q2
$92K Sell
2,318
-117
-5% -$3.83K ﹤0.01% 2799
2025
Q1
$73K Buy
2,435
+384
+19% +$12.6K ﹤0.01% 2675
2024
Q4
$72K Buy
2,051
+310
+18% +$11.6K ﹤0.01% 2508
2024
Q3
$70K Sell
1,741
-476
-21% -$22.1K ﹤0.01% 2438
2024
Q2
$106K Sell
2,217
-11
-0.5% -$451 ﹤0.01% 1939
2024
Q1
$97K Buy
2,228
+31
+1% +$1.48K ﹤0.01% 1899
2023
Q4
$111K Sell
2,197
-9
-0.4% -$431 ﹤0.01% 1694
2023
Q3
$100K Sell
2,206
-22
-1% -$908 ﹤0.01% 1632
2023
Q2
$91K Buy
2,228
+306
+16% +$11.8K ﹤0.01% 1615
2023
Q1
$69K Buy
1,922
+85
+5% +$3.19K ﹤0.01% 1691
2022
Q4
$69K Sell
1,837
-126
-6% -$5.3K ﹤0.01% 1555
2022
Q3
$87K Buy
1,963
+244
+14% +$10.3K ﹤0.01% 1397
2022
Q2
$64K Buy
1,719
+165
+11% +$6.22K ﹤0.01% 1514
2022
Q1
$58K Buy
1,554
+555
+56% +$18.2K ﹤0.01% 1537
2021
Q4
$30K Buy
+999
New +$31.4K ﹤0.01% 1779
2021
Q2
$28K Hold
690
﹤0.01% 1644
2021
Q1
$28K Hold
690
﹤0.01% 1644
2020
Q4
$28K Hold
690
﹤0.01% 1644
2020
Q3
$28K Hold
690
﹤0.01% 1644
2020
Q2
$28K Hold
690
﹤0.01% 1644
2020
Q1
$28K Hold
690
﹤0.01% 1644
2019
Q4
$28K Hold
690
﹤0.01% 1644
2019
Q3
$28K Hold
690
﹤0.01% 1644
2019
Q2
$28K Hold
690
﹤0.01% 1644
2019
Q1
$28K Buy
690
+566
+456% +$36.5K ﹤0.01% 1644
2018
Q4
$7K Sell
124
-215
-63% -$11K ﹤0.01% 1444
2018
Q3
$17K Hold
339
﹤0.01% 993
2018
Q2
$14K Buy
339
+21
+7% +$931 ﹤0.01% 913
2018
Q1
$14K Buy
318
+62
+24% +$3.15K ﹤0.01% 778
2017
Q4
$13K Hold
256
﹤0.01% 817
2017
Q3
$13K Sell
256
-2
-0.8% -$105 ﹤0.01% 828
2017
Q2
$13K Buy
258
+88
+52% +$4.1K ﹤0.01% 724
2017
Q1
$7K Hold
170
﹤0.01% 820
2016
Q4
$8K Buy
170
+168
+8,400% +$6.65K ﹤0.01% 770
2016
Q3
$0 Hold
2
﹤0.01% 1025
2016
Q2
$0 Buy
+2
New +$65 ﹤0.01% 827

Other funds holding IONS

Carson Wealth (CWM LLC)'s IONS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Ionis Pharmaceuticals (IONS) stake by 26% in Q1 2026, selling an estimated $105K and leaving 3,717 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.

Carson Wealth (CWM LLC) first reported a position in IONS in Q2 2016 and has held it in 39 quarters since. The position peaked at $399K in Q4 2025. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Carson Wealth (CWM LLC) held 3,717 shares of Ionis Pharmaceuticals worth $279K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 1,332 Ionis Pharmaceuticals shares in Q1 2026, an estimated $105K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2436 holding.
  • Carson Wealth (CWM LLC) first reported a position in Ionis Pharmaceuticals in Q2 2016 and has held it in 39 quarters since.
  • Carson Wealth (CWM LLC)'s Ionis Pharmaceuticals position peaked at $399K in Q4 2025.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.